BLAKE PHIPPS: Open Payments
NPI 1689084477 · LAWRENCE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$357 in 21 payments from 10 companies in 2025. Trend: 2023 $223 · 2024 $469 · 2025 $357
Food & beverage: $357
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 6 | $102 |
| ABBVIE INC. | 4 | $73 |
| Lilly USA, LLC | 3 | $45 |
| Astellas Pharma US Inc | 2 | $32 |
| Boston Scientific Corporation | 1 | $23 |
| Seqirus USA Inc | 1 | $21 |
| Amgen Inc. | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $15 |
| Insulet Corporation | 1 | $14 |
| Novo Nordisk Inc | 1 | $14 |
Products named: PREVNAR 20, UBRELVY, QULIPTA, Veozah, JARDIANCE, WATCHMAN FLX, Fluad, REPATHA.
Industry payments across KS — which companies pay providers there.
